United Kingdom · Question · Written question
UIN 15627
Metabolic Dysfunction-associated Steatohepatitis
Introduced
2 July 2026
Last action
10 July 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 July 2026
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of retiring the OHID Liver Disease Fingertips Profiles on the UK's ability to monitor steatotic liver disease indicators and meet the World Healt
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 July 2026
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of retiring the OHID Liver Disease Fingertips Profiles on the UK's ability to monitor steatotic liver disease indicators and meet the World Healt
Source: Commons
10 July 2026
Answer
The Office for Health Improvement and Disparities (OHID) continues to monitor a wide range of indicators relating to steatotic liver disease, an umbrella term that includes a range of conditions where fat accumulates in liver cells causing dysfunction. In...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-07-02/15627
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1923643
- uk · wq-1923643 · source updated 10 July 2026